About Hayat Pharmaceutical Consultants Services
Hayat Pharmaceutical Consulting is a USA based services-oriented organization established in 2016 by Dr. Umar Hayat to serve the pharmaceutical industry. With over multiple decades of experience and reputation among the industry leader, HPC has become a bigger with additions of industry experts in the areas of formulation development, analytical development, quality assurance, business strategies, collaboration and funding, project and assets assessment to help our clients to succeed their goal and to HPC fulfil their mission of providing most needed treatments to patients.
HPC provides pharma consulting services for drug development, clinical trial logistics, and commercial manufacturing through global experts and partners. We collaborate with our customers in the pharmaceutical, biotech, and life sciences industries as their trusted CDMO to deliver medicine to patients faster. We believe that doing this successfully not only requires science, technology, and world-class expertise, but also requires a strategic partnership—bonded by key elements such as trust, communication, and collaboration. We embed these elements into every operation, interaction, and step in the drug development journey.
We are committed to providing integrated, end-to-end solutions across all phases of development. Our services include API, drug product formulation, clinical trials solutions, logistics services, and commercial manufacturing, and packaging. We couple our scientific and technical excellence in these areas with a strategic partnership, to provide customers of all sizes access to a global network of facilities and dedicated experts across the Americas, Europe, Asia, and Australia.
At HPC, we understand that developing novel therapies and moving them from discovery to patients is a complex, high-risk process. Every customer has different needs, and every newly discovered drug has a unique pathway to reach to the market. As a global service provider, we help our partners bring innovative molecules and life-changing therapies to market as efficiently and safely as possible.
Assurance of quality
Success in business is based on trust, especially in pharmaceuticals. By putting quality at the core of everything we do, Patheon pharma services has earned the trust of clients around the world—and those companies in turn have secured the trust of patients. Trust has been earned through regulatory compliance, and safe and effective products. It is our uncompromising quality that continues to build our client relationships and strategic partnerships. We pursue improvement in every functional area of the business, proactively seek out opportunities to prevent problems before they occur.
Clients We Serve
Emerging pharma and biotech
We understand the unique challenges faced by emerging pharmaceutical and biotech companies, including funding constraints, intense time pressures, and the need to build experience and resources beyond the discovery phase. Every day we help remove the barriers that stand between exciting, new discoveries and the patients who need them. We provide instant access to comprehensive capabilities for drug development, clinical trial logistics, and commercial manufacturing of both large and small molecule drug substances and drug products across a wide range of finished dosage forms. We bring formulation and process development expertise to pursue early-phase goals and establish a scientifically sound foundation for success in later stages and beyond. What’s best is HPC provides unique solutions dedicated to helping small companies at every turn on their path to market.
Midsize pharma:
Many of midsize pharma companies are
transforming the way pharmaceuticals are developed and commercialized with a
new vision for their business model. HPC services is their means to turn that
vision into reality. Many midsize companies can benefit from a virtual model
with ready access to world-class facilities, technologies, talent, and quality
to build highly customized development and manufacturing solutions. This
outsourced model provides the agility to quickly scale up or down in response
to market conditions, enabling companies to have a lean infrastructure and to
focus on their core strengths in discovery and marketing. This model keeps
midsized firms from becoming mired in an overly complex supply chain of
multiple specialized vendors. We can offer these companies a strategic
partnership with our end-to-end capabilities taking their discovery all the way
from the lab bench to the patient bedside.
